Stachydrine, a potential drug for the treatment of cardiovascular system and central nervous system diseases
Open Access
- 20 March 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 161, 114489
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic ImplicationsMedicinal Research Reviews, 2013
- Stachydrine ameliorates high-glucose induced endothelial cell senescence and SIRT1 downregulationJournal of Cellular Biochemistry, 2013
- Six Alkaloids Inhibit Secretion of IL-1α, TXB2, ET-1 and E-selectin in LPS-induced Endothelial CellsImmunological Investigations, 2011
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- The myofibroblast: Paradigm for a mechanically active cellJournal of Biomechanics, 2010
- Identification of anti-asthmatic compounds in Pericarpium citri reticulatae and evaluation of their synergistic effectsActa Pharmacologica Sinica, 2009
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005
- Proline Betaine Accumulation and Metabolism in Alfalfa Plants under Sodium Chloride Stress. Exploring Its Compartmentalization in NodulesPlant Physiology, 2004
- The amyloid β peptide Aβ (25–35) induces apoptosis independent of p53FEBS Letters, 2000
- Endothelial cell activationBMJ, 1998